Top

BMC Psychiatry

Published in:

Open Access 01-12-2021 | Mood Disorders | Research article

Posttraumatic stress disorder (PTSD) and depression severity in sexually assaulted women: hypothalamic-pituitary-adrenal (HPA) axis alterations

Authors: Ana Teresa D. D’Elia, Mario F. Juruena, Bruno M. Coimbra, Marcelo F. Mello, Andrea F. Mello

Published in: BMC Psychiatry | Issue 1/2021

Abstract

Background

Sexual assault is implicated in several adverse psychological and physical health outcomes, including posttraumatic stress disorder (PTSD) and depression. Neurobiological research has shown variations related to the hypothalamic-pituitary-adrenal (HPA) axis, immune alterations, metabolic function, and brain circuitry. Although these mechanisms have been extensively studied, the results have demonstrated different outcomes in PTSD.

Methods

We compared the plasma adrenocorticotropin (ACTH) and salivary cortisol levels of fifty-eight women with PTSD developed after sexual assault to those of forty-four female controls with no history of trauma. We also evaluated the psychiatric diagnosis and symptom severity of PTSD and depression. The participants’ clinical conditions were associated with their hormonal levels to assess whether symptom severity was related to hormonal imbalance.

Results

A large percentage of sexually assaulted women had PTSD and comorbid depression. The ACTH levels were higher in the PTSD group than the control group and increased as PTSD severity increased, considering depressive symptoms, measured by the Beck Depression Inventory (BDI) (p < 0.0001), as well as PTSD symptoms, measured by subscale D of the Clinician-Administered PTSD Scale (CAPS-5) (p = 0.045) and the CAPS-5 total scale (p = 0.026). Cortisol levels measured at 10 pm were higher for the PTSD group than the control group (p = 0.045, p = 0.037, respectively), and the cortisol awakening response showed elevated cortisol levels for the PTSD group.

Conclusions

These results show a correlation between symptom severity and HPA axis imbalance in patients with PTSD. Elevated ACTH and an elevated cortisol response in patients with comorbid depressive symptoms were the opposite of the expected response for patients with PTSD only. This association leads to the hypothesis that the neurobiological alterations of PTSD are related to the type of symptoms presented and their severity. These manifestations likely influence the disease course, prognosis and response to treatment. These outcomes highlight the need to discuss particular neurobiological alterations in patients with PTSD developed after sexual assault, mainly those with severe depressive symptoms.

Available only for authorised users

World Health Organization. Global and regional estimates of violence against women: prevalence and health effects of intimate partner violence and non-partner sexual violence. WHO Libr Cat Data. 2013.

Boscarino JA. Posttraumatic stress disorder and physical illness: results from clinical and epidemiologic studies. Annals of the New York Academy of Sciences. 2004. 141–153.

Chivers-Wilson KA. Sexual assault and posttraumatic stress disorder: a review of the biological, psychological and sociological factors and treatments. McGill J Med. 2006;9(2):111.PubMedPubMedCentral

Campbell JC. Health consequences of intimate partner violence. Lancet. 2002;359(9314):1331–6. https://doi.org/10.1016/S0140-6736(02)08336-8.CrossRefPubMed

Thurston RC, Chang Y, Matthews KA, Von Känel R, Koenen K. Association of Sexual Harassment and Sexual Assault with Midlife Women’s mental and physical health. JAMA Internal Med. 2019;179(1):48.CrossRef

Ulirsch JC, Ballina LE, Soward AC, Rossi C, Hauda W, Holbrook D, et al. Pain and somatic symptoms are sequelae of sexual assault: Results of a prospective longitudinal study. Eur J Pain (United Kingdom). 2014;18(4):559.

Yehuda R, Hoge CW, McFarlane AC, Vermetten E, Lanius RA, Nievergelt CM, et al. Post-traumatic stress disorder. Nat Rev Dis Prim. 2015;1(1):15058. https://doi.org/10.1038/nrdp.2015.58.CrossRef

Luz MP, Coutinho ESF, Berger W, Mendlowicz MV, Vilete LMP, Mello MF, et al. Conditional risk for posttraumatic stress disorder in an epidemiological study of a Brazilian urban population. J Psychiatr Res. 2016;72:51–7.CrossRef

Steven Betts K, Williams GM, Najman JM, Alati R. Exploring the Female Specific Risk to Partial and Full PTSD Following Physical Assault. J Trauma Stress. 2013;26(1):86.CrossRef

10.

Hepp U, Gamma A, Milos G, Eich D, Ajdacic-Gross V, Rössler W, et al. Prevalence of exposure to potentially traumatic events and PTSD: the Zurich cohort study. Eur Arch Psychiatry Clin Neurosci. 2006;256(3):151–8. https://doi.org/10.1007/s00406-005-0621-7.CrossRefPubMed

11.

Juruena MF, Cleare AJ, Bauer ME, Pariante CM. Molecular mechanisms of glucocorticoid receptor sensitivity and relevance to affective disorders. Acta Neuropsychiatrica. 2003;15(6):354.CrossRef

12.

Yehuda R. Current status of cortisol findings in post-traumatic stress disorder. Psychiatr Clin N Am. 2002;25(2):341–68. https://doi.org/10.1016/S0193-953X(02)00002-3.CrossRef

13.

Zoladz PR, Diamond DM. Current status on behavioral and biological markers of PTSD: a search for clarity in a conflicting literature. Neurosci Biobehav Rev. 2013;37(5):860–95. https://doi.org/10.1016/j.neubiorev.2013.03.024.CrossRefPubMed

14.

Flory JD, Yehuda R. Comorbidity between post-traumatic stress disorder and major depressive disorder: alternative explanations and treatment considerations. Dialogues Clin Neurosci. 2015;17(2):141.CrossRef

15.

Bovin MJ, Marx BP, Weathers FW, Gallagher MW, Rodriguez P, Schnurr PP, et al. Psychometric properties of the PTSD checklist for diagnostic and statistical manual of mental disorders-fifth edition (PCL-5) in veterans. Psychol Assess. 2016;28(11):1379–91. https://doi.org/10.1037/pas0000254.CrossRefPubMed

16.

Weathers FW, Bovin MJ, Lee DJ, Sloan DM, Schnurr PP, Kaloupek DG, et al. The clinician-administered ptsd scale for DSM-5 (CAPS-5): development and initial psychometric evaluation in military veterans. Psychol Assess. 2018;30(3):383–95. https://doi.org/10.1037/pas0000486.CrossRefPubMed

17.

Elhai JD, de Francisco CL, Miguel FK, Palmieri PA, Primi R, Christopher Frueh B. Testing whether posttraumatic stress disorder and major depressive disorder are similar or unique constructs. J Anxiety Disord. 2011;25(3):404.CrossRef

18.

Price M, Legrand AC, Brier ZMF, Hébert-Dufresne L. The symptoms at the center: examining the comorbidity of posttraumatic stress disorder, generalized anxiety disorder, and depression with network analysis. J Psychiatr Res. 2019;109:52–8. https://doi.org/10.1016/j.jpsychires.2018.11.016.CrossRefPubMed

19.

Lazarov A, Suarez-Jimenez B, Levi O, DDL C, Lubin G, Pine DS, et al. Symptom structure of PTSD and co-morbid depressive symptoms- a network analysis of combat veteran patients. Psychol Med. 2020;50(13):2154.CrossRef

20.

de Kloet C, Vermetten E, Lentjes E, Geuze E, van Pelt J, Manuel R, et al. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder. Psychoneuroendocrinology. 2008;33(3):313.CrossRef

21.

Heim C, Newport D, Heit S. al et. PItuitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA. 2000;284(5):592–7. https://doi.org/10.1001/jama.284.5.592.CrossRefPubMed

22.

Young EA, Breslau N. Saliva cortisol in posttraumatic stress disorder: a community epidemiologic study. Biol Psychiatry. 2004;56(3):205.CrossRef

23.

Rasmusson AM, Lipschitz DS, Wang S, Hu S, Vojvoda D, Bremner JD, et al. Increased pituitary and adrenal reactivity in premenopausal women with posttraumatic stress disorder. Biol Psychiatry. 2001;50(12):965.CrossRef

24.

Morris MC, Compas BE, Garber J. Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: a systematic review and meta-analysis. Clin Psychol Rev. 2012;32(4):301–15. https://doi.org/10.1016/j.cpr.2012.02.002.CrossRefPubMedPubMedCentral

25.

Juruena MF, Cleare AJ, Papadopoulos AS, Poon L, Lightman S, Pariante CM. Different responses to dexamethasone and prednisolone in the same depressed patients. Psychopharmacology. 2006;189(2):225.CrossRef

26.

Coimbra BM, Yeh M, D’Elia AT, Maciel MR, Carvalho CM, Milani AC, et al. Posttraumatic stress disorder and neuroprogression in women following sexual assault: protocol for a randomized clinical trial evaluating allostatic load and aging process acceleration. JMIR Res Protoc. 2020;9(11):e19162. https://doi.org/10.2196/19162.CrossRefPubMedPubMedCentral

27.

Amorim P. MINI international neuropsychiatric interview (MINI). Rev Bras Psiquiatr. 2002;22:106–15.CrossRef

28.

Oliveira-Watanabe TT, Ramos-Lima LF, Santos RC, Mello MF, Mello AF. The clinician-administered PTSD scale (CAPS-5): adaptation to Brazilian Portuguese. Braz J Psychiatry. 2019;41(1):92–3. https://doi.org/10.1590/1516-4446-2018-0136.CrossRefPubMedPubMedCentral

29.

Cunha JA. Escalas Beck - manual; 2001.

30.

Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck depression inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8(1):77–100. https://doi.org/10.1016/0272-7358(88)90050-5.CrossRef

31.

Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893–7. https://doi.org/10.1037/0022-006X.56.6.893.CrossRefPubMed

32.

Grassi-Oliveira R, Stein LM, Pezzi JC. Translation and content validation of the Childhood Trauma Questionnaire into Portuguese language. Rev saúde pública. 2006;40:249–55. https://doi.org/10.1590/s0034-89102006000200010.CrossRefPubMed

33.

Roy CA, Perry JC. Instruments for the assessment of childhood trauma in adults. J Nerv Ment Dis. 2004;192(5):343–51. https://doi.org/10.1097/01.nmd.0000126701.23121.fa.CrossRefPubMed

34.

Stalder T, Kirschbaum C, Kudielka BM, Adam EK, Pruessner JC, Wüst S, et al. Assessment of the cortisol awakening response: expert consensus guidelines. Psychoneuroendocrinology. 2016;63:414.CrossRef

35.

Kirschbaum C, Hellhammer DH. Salivary cortisol in psychobiological research: an overview. Neuropsychobiology. 1989;22(3):150–69. https://doi.org/10.1159/000118611.CrossRefPubMed

36.

Rytwinski NK, Scur MD, Feeny NC, Youngstrom EA. The co-occurrence of major depressive disorder among individuals with posttraumatic stress disorder: a meta-analysis. J Trauma Stress. 2013;26(3):299–309. https://doi.org/10.1002/jts.21814.CrossRefPubMed

37.

O’Donnell ML, Creamer M, Pattison P. Posttraumatic stress disorder and depression following trauma: understanding comorbidity. Am J Psychiatry. 2004;161(8):1390–6. https://doi.org/10.1176/appi.ajp.161.8.1390.CrossRefPubMed

38.

Nijdam MJ, Gersons BPR, Olff M. The role of major depression in neurocognitive functioning in patients with posttraumatic stress disorder. Eur J Psychotraumatol. 2013;4(1):19979. https://doi.org/10.3402/ejpt.v4i0.19979.CrossRef

39.

Ramsawh HJ, Fullerton CS, Mash HBH, THH N, Kessler RC, Stein MB, et al. Risk for suicidal behaviors associated with PTSD, depression, and their comorbidity in the U.S. Army. J Affect Disord. 2014;161:116.CrossRef

40.

Juruena MF. Early-life stress and HPA axis trigger recurrent adulthood depression. Epilepsy Behav. 2014;38:148–59. https://doi.org/10.1016/j.yebeh.2013.10.020.CrossRefPubMed

41.

Zunszain PA, Anacker C, Cattaneo A, Carvalho LA, Pariante CM. Glucocorticoids, cytokines and brain abnormalities in depression. Progress Neuro-Psychopharmacol Biol Psychiatry. 2011;35(3):722.CrossRef

42.

Tofoli SM de C, Baes C von W, Martins CMS, Juruena M. Early life stress, HPA axis, and depression. Psychol Neurosci. 2011.

43.

Yehuda R, Flory JD, Bierer LM, Henn-Haase C, Lehrner A, Desarnaud F, et al. Lower methylation of glucocorticoid receptor gene promoter 1F in peripheral blood of veterans with posttraumatic stress disorder. Biol Psychiatry. 2015;77(4):356–64. https://doi.org/10.1016/j.biopsych.2014.02.006.CrossRefPubMed

44.

Young EA, Carlson NE, Brown MB. Twenty-four-hour ACTH and cortisol pulsatility in depressed women. Neuropsychopharmacology. 2001;25(2):267.CrossRef

45.

Miller MW, Lin AP, Wolf EJ, Miller DR. Oxidative stress, inflammation, and neuroprogression in chronic PTSD. Harvard Rev Psychiatry. 2018;26(2):57.CrossRef

46.

Miller MW, Sadeh N. Traumatic stress, oxidative stress and post-traumatic stress disorder: Neurodegeneration and the accelerated-aging hypothesis. Mol Psychiatry. 2014;19(11):1156–62. https://doi.org/10.1038/mp.2014.111.CrossRefPubMedPubMedCentral

47.

Rasmusson AM, Pineles SL. Neurotransmitter, peptide, and steroid hormone abnormalities in PTSD: biological Endophenotypes relevant to treatment. Curr Psychiatry Rep. 2018;20(7). https://doi.org/10.1007/s11920-018-0908-9.

48.

Groer MW, Thomas SP, Evans GW, Helton S, Weldon A. Inflammatory Effects and Immune System Correlates of Rape. Violence Vict. 2006;21(6):796.CrossRef

49.

Imel ZE, Laska K, Jakupcak M, Simpson TL. Meta-analysis of dropout in treatments for posttraumatic stress disorder. J Consult Clin Psychol. 2013;81(3):394–404. https://doi.org/10.1037/a0031474.CrossRefPubMedPubMedCentral

50.

Rasmusson AM, Marx CE, Pineles SL, Locci A, Scioli-Salter ER, Nillni YI, et al. Neuroactive steroids and PTSD treatment. Neurosci Lett. 2017;649:156.CrossRef

51.

Pineles SL, Nillni YI, Pinna G, Irvine J, Webb A, Arditte Hall KA, et al. PTSD in women is associated with a block in conversion of progesterone to the GABAergic neurosteroids allopregnanolone and pregnanolone measured in plasma. Psychoneuroendocrinology. 2018;93:133.CrossRef

52.

El-Farhan N, Rees DA, Evans C. Measuring cortisol in serum, urine and saliva – are our assays good enough? Annals of clinical biochemistry; 2017.

Title: Posttraumatic stress disorder (PTSD) and depression severity in sexually assaulted women: hypothalamic-pituitary-adrenal (HPA) axis alterations
Authors: Ana Teresa D. D’Elia
Mario F. Juruena
Bruno M. Coimbra
Marcelo F. Mello
Andrea F. Mello
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Mood Disorders
Affective Disorder
Published in: BMC Psychiatry / Issue 1/2021
Electronic ISSN: 1471-244X
DOI: https://doi.org/10.1186/s12888-021-03170-w

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Posttraumatic stress disorder (PTSD) and depression severity in sexually assaulted women: hypothalamic-pituitary-adrenal (HPA) axis alterations

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Regional brain volume predicts response to methylphenidate treatment in individuals with ADHD

Impaired cognitive functioning in stress-induced exhaustion disorder: a new tablet-based assessment

Clinical outcomes of paliperidone long-acting injection in patients with schizophrenia: a 1-year retrospective cohort study

Associations between substandard housing and depression: insights from the Korea welfare panel study

An investigation of the association between religious coping, fatigue, anxiety and depressive symptoms during the COVID-19 pandemic in Morocco: a web-based cross-sectional survey

Now and then: a ten-year comparison of young people in residential substance use disorder treatment receiving group dialectical behaviour therapy